Yansun Sun

Dr. Yansun Sun


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
HZHe-Yang Zhang
He-Yang Zhang
YWYan Wang
Yan Wang
YHYoudi He
Youdi He
TWTing Wang
Ting Wang
XHXiao-Hui Huang
Xiao-Hui Huang
XJXIAO-XIA JIANG
XIAO-XIA JIANG
Background: Astrocytes are crucial regulators in the central nervous system. Abnormal activation of astrocytes contributes to some behavior deficits. However, mechanisms underlying the effects remain unclear. Here, we studied the activation of A1 astrocytes and their contribution to murine behavior deficits.Methods: A1 astrocytes were induced by treatment with lipopolysaccharide (LPS) in vitro. The functional phenotype of astrocytes was determined by quantitative RT-PCR, ELISA, and immunohistochemistry. To assess the role of A1 astrocytes in vivo, mice were injected intraperitoneally with LPS. Then, murine behaviors were tested, and the hippocampus and cortex were analyzed by quantitative RT-PCR, ELISA, and immunohistochemistry. The function of IL-10 and fluorocitrate on A1 astrocyte activation was also examined.Results: Our results show that astrocytes isolated from B6.129S6-Il10tm1Flv/J homozygotes (IL-10tm1/tm1) were prone to characteristics of A1 reactive astrocytes. Compared with their wild-type counterparts, IL-10tm1/tm1astrocytes exhibited higher expression of glial fibrillary acidic protein (GFAP). Whether or not they were stimulated with LPS, IL-10tm1/tm1astrocytes exhibited enhanced expression of A1-specific transcripts and proinflammatory factors IL-1β, IL-6, and TNFα. In addition, IL-10tm1/tm1astrocytes demonstrated hyperphosphorylation of STAT3. Moreover, astrocytes from IL-10tm1/tm1mice showed attenuated phagocytic ability and were neurotoxic. IL-10tm1/tm1mice demonstrated increased immobility time in the forced swim test and defective learning and memory behavior in the Morris water maze test. Moreover, enhanced neuroinflammation was found in the hippocampus and cortex of IL-10tm1/tm1mice, accompanying with more GFAP-positive astrocytes and severe neuron loss in the hippocampus. Pretreatment IL-10tm1/tm1mice with IL-10 or fluorocitrate decreased the expression of proinflammatory factors and A1-specific transcripts in the hippocampus and cortex, and then alleviated LPS-induced depressive-like behavior.Conclusion: These results demonstrate that astrocytes isolated from B6.129S6-Il10tm1Flv/J homozygotes are prone to A1 phenotype and contribute to the depression-like behavior and memory deficits. Inhibiting A1 astrocyte activation may be an attractive therapeutic strategy in some neurodegenerative diseases.

18 December 2025 in Immunologic Research
Verified
Journal Article
Open access
PDF file
YSYansun Sun
Yansun Sun
LWLing Wang
Ling Wang
LLLiu Li
Liu Li
YSYansun Sun
Yansun Sun
Background Cardiovascular-kidney-metabolic (CKM) syndrome is a major public health concern associated with increased mortality. Inflammation plays a critical role in CKM progression and outcomes. This study investigates the relationship between inflammatory indices and mortality risk in CKM patients. Methods A comprehensive analysis of data from 26,265 participants in the National Health and Nutrition Examination Survey (NHANES) database (2007–2016) with CKM syndrome stages 0–4 was conducted. The primary outcomes of the study were all-cause and cardiovascular mortality. The inflammatory indices encompassed the systemic inflammation response index (SIRI), neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), aggregate index of systemic inflammation (AISI), and neutrophil-to-albumin ratio (NAR). Multivariable Cox models, adjusted for demographic and clinical confounders, were employed to examine nonlinearity, alongside restricted cubic splines and threshold analyses. The present study sought to compare the prognostic accuracy of the time-dependent ROC (Receiver Operating Characteristic) at 93 months. Results During a median follow-up of 93.4 months, 2,292 subjects experienced all-cause mortality and 701 experienced cardiovascular deaths. In the adjusted models, elevated SIRI (all-cause HR 1.11, 95% CI 1.06–1.15; cardiovascular HR 1.18, 1.10–1.27), NLR (all-cause HR 1.08, 1.05–1.12; cardiovascular HR 1.11, 1.05–1.17) and MLR (all-cause HR 2.27, 1.71–3.01; cardiovascular HR 3.37, 2.09–5.44) were independently associated with mortality (all p < 0.0001). Dose–response analyses revealed nonlinear J-shaped relationships: MLR showed marked risk above 0.19 (HR 2.59), NLR risk was greatest below 3 (HR 1.14), and SIRI thresholds differed for all-cause (> 1.74, HR 1.09) versus cardiovascular (> 0.38, HR 1.17) outcomes. At 93 months, MLR demonstrated the highest discriminatory ability (AUC 0.630; C-index 0.667; p < 0.001), outperforming SIRI (AUC 0.611) and NLR (AUC 0.602). PLR, AISI, SII and NAR showed limited predictive value due to imbalanced sensitivity–specificity. The impact of age and the early stages of CKD on the modification of associations was investigated. Conclusion Systemic inflammatory indices demonstrated nonlinear, J-shaped associations with mortality in CKM syndrome, with the MLR showing the strongest association across disease trajectories. MLR, NLR, and SIRI were identified as potential risk indicators, with stronger associations observed in younger patients and those with early-stage CKM syndrome. Highlights Systemic inflammatory markers (SIRI, NLR, MLR) were significantly associated with increased mortality risk in CKM syndrome. Most inflammation indices exhibited nonlinear, J-shaped associations with mortality. Nonlinear threshold analyses identified specific risk inflection points for SIRI, NLR, and MLR. These associations were stronger in younger patients (≤ 60 years) and those with early CKM stages (1–2).

Verified
Journal Article
Open access
PDF file
XHXIAO HE
XIAO HE
YSYansun Sun
Yansun Sun
SXSu Xiong
Su Xiong
ZJZhiru Jiang
Zhiru Jiang
YTyaqin tang
yaqin tang
YSYansun Sun
Yansun Sun
The utilization of cytosolic protein delivery is a promising approach for treating various diseases by replacing dysfunctional proteins. Despite the development of various nanoparticle-based intracellular protein delivery methods, the complicated chemical synthesis of the vector, loading efficiency and endosomal escape efficiency of proteins remain a great challenge. Recently, 9-fluorenylmethyloxycarbonyl (Fmoc)-modified amino acid derivatives have been used to self-assemble into supramolecular nanomaterials for drug delivery. However, the instability of the Fmoc group in aqueous medium restricts its application. To address this issue, the Fmoc ligand neighboring arginine was substituted for dibenzocyclooctyne (DBCO) with a similar structure to Fmoc to obtain stable DBCO-functionalized L-arginine derivative (DR). Azide-modified triethylamine (crosslinker C) was combined with DR to construct self-assembled DRC via a click chemical reaction for delivering various proteins, such as BSA and saporin (SA), into the cytosol of cells. The hyaluronic-acid-coated DRC/SA was able to not only shield the cationic toxicity, but also enhance the intracellular delivery efficiency of proteins by targeting CD44 overexpression on the cell membrane. The DRC/SA/HA exhibited higher growth inhibition efficiency and lower IC50 compared to DRC/SA toward various cancer cell lines. In conclusion, DBCO-functionalized L-arginine derivative represents an excellent potential vector for protein-based cancer therapy.

22 February 2025 in International Journal of Diabetes in Developing Countries
Verified
Journal Article
Open access
PDF file
QWQun Wan
Qun Wan
ZLZhiwei Li
Zhiwei Li
BLBo Li
Bo Li
YSYansun Sun
Yansun Sun
Background: Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder with a significant impact on global health. Insulin pump therapy has emerged as a promising approach for achieving tight glycemic control, mimicking the body's natural insulin secretion patterns. However, the optimization of insulin dosage remains a challenge, influenced by various patient-specific factors. Additionally, dietary management, including weighed diets, plays a crucial role in the overall glycemic control of patients with T2DM. Understanding the factors that influence insulin dosage adjustments and the impact of dietary interventions is essential for personalized treatment strategies and improving patient outcomes. Objective: To investigate and analyze the influencing factors of insulin dosage and the role of weighed diet on type 2 diabetic patients treated with insulin pump. Methods: A total of 328 patients with type 2 diabetes who were hospitalized and treated with insulin pump in our endocrinology department from June 2022 to December 2023 were collected and reviewed. Participants were stratified based on changes in their insulin dosage per unit body weight within the first 24 h following hospital admission. A comparative analysis of clinical characteristics between groups with increased or decreased dosages was performed, along with an examination of the factors influencing insulin dosage adjustments. Additionally, the role of weighed diet in diabetes patients treated with insulin pumps was assessed. Results: In this study, the average body mass index (BMI), glycated hemoglobin (HbA1c), and triglyceride (TG) were 25.86 ± 3.76 kg/m2, 10.86 ± 6.11%, and 2.60 ± 0.19 mmol/L, respectively. Patients in the group with an increased insulin dosage per unit body weight exhibited significantly elevated low-density lipoprotein cholesterol (LDL-c) levels, as well as higher fasting plasma glucose and C-peptide and 2-h postprandial C-peptide levels during the 75 g oral glucose tolerance test (OGTT). The magnitude of insulin dosage increase was markedly greater in the increased group. Fasting plasma glucose at discharge and average 2-h postprandial glucose in 24 h of discharge and admission were significantly higher in the increased dosage group, and the frequency of achieving target blood glucose levels within this timeframe was significantly lower (all p < 0.05). Regression analysis showed that the disease duration, fasting blood glucose of OGTT, and average 2-h postprandial blood glucose of 24 h after admission were positively correlated with the increase of insulin dosage (β = 0.89, 1.01, 0.232, 0.274, all p < 0.05), while adherence to a weighed diet was negatively associated with increased insulin dosage (β = − 1.05, p < 0.05). Patients adhering to a weighed diet were younger, had shorter hospital stays, and presented with higher admission HbA1c levels. Notably, the weighed diet group exhibited a significant reduction in fasting and 2-h postprandial glucose levels at discharge, alongside a greater attainment of blood glucose targets (all p < 0.05). Conclusion: Timely initiation of hypoglycemic therapy is crucial for patients with T2DM. The concomitant use of insulin pumps and adherence to a diabetic diet can alleviate the burden of insulin dosage requirements and enhance the achievement of blood glucose targets, thereby optimizing patient outcomes.

1 July 2025 in Open Heart
Verified
Journal Article
Open access
PDF file
WLWang Ling
Wang Ling
HLHongde Li
Hongde Li
LLLi Liu
Li Liu
YSYansun Sun
Yansun Sun
YSYansun Sun
Yansun Sun
Objective: To evaluate the association between β-blocker use and all-cause mortality in a real-world cohort of patients with myocardial infarction (MI). Methods: This study included 2308 patients with MI from the National Health and Nutrition Examination Survey (NHANES) 1999–2018. The primary outcome was all-cause mortality. Multiple approaches were employed to control for confounding, including multivariable Cox regression, propensity score matching and inverse probability of treatment weighting. Results: Based on data from 2308 patients with MI in the NHANES 1999–2018, with a mean follow-up of 84.6 months, this study evaluated the association between β-blocker use and all-cause mortality. The unadjusted analysis showed a significant protective effect (HR 0.81, 95% CI 0.68 to 0.96, p=0.0178). However, after multivariable adjustment for demographic, clinical and socioeconomic factors, as well as propensity score-based methods and inverse probability of treatment weighting, no significant association was observed (e.g., adjusted HR 1.04, 95% CI 0.87 to 1.25, p=0.6733). Stratified analyses did not reveal significant effect modification by any covariate (all p interaction value >0.05). Conclusion: After adjustment for measured confounders, this analysis found no significant association between β-blocker use and all-cause mortality in this real-world MI cohort.

26 June 2026 in Medicine
Verified
Journal Article
Open access
YSYansun Sun
Yansun Sun
LWLing Wang
Ling Wang
ZLZhiwei Li
Zhiwei Li
LLLi Liu
Li Liu
YSYansun Sun
Yansun Sun
The relationship between serum uric acid (UA) and mortality in patients with cardiovascular-kidney-Metabolic (CKM) syndrome remains unclear. We hypothesized that elevated UA increases mortality nonlinearly and is partly mediated by vitamin D. Using NHANES data (2007–2016) from 25,979 adults with CKM stages 0 to 4, we performed Cox regression, threshold analysis, and causal mediation analysis. During a median follow-up of 93.0 months, 2264 all-cause and 689 cardiovascular deaths occurred. A J-shaped relationship existed between UA and mortality. Each 1 mg/dL increase in UA increased fully adjusted risks of all-cause (HR = 1.06, 95% CI: 1.02–1.09) and cardiovascular mortality (HR = 1.11, 95% CI: 1.04–1.18). Thresholds were identified at 6.6 mg/dL and 7.1 mg/dL. Participants aged ≤60 years showed higher all-cause mortality risk (HR = 1.15, 95% CI: 1.06–1.25). Serum 25(OH)D negatively correlated with UA (β = −0.064, P < .00001) and mediated 14.55% of its effect on all-cause mortality. High UA beyond specific thresholds predicts mortality in CKM syndrome, partially mediated by vitamin D. Interventions on UA and vitamin D may improve outcomes.